About Trinity Biomedical Sciences Institute
The Trinity Biomedical Sciences Institute (TBSI) is an environment where innovative and interdisciplinary approaches are leading to scientific discoveries of biomedical importance, ultimately giving rise to better patient care. The mechanistic basis for a whole range of diseases is under investigation, including infectious and inflammatory diseases such as arthritis and Type 2 diabetes, neurological diseases such as motor neuron disease and multiple sclerosis, and different forms of cancer.
Our focus is on outstanding discovery, since there remains a major unmet medical need for the treatment of these diseases and our understanding of the molecular basis of many diseases remains limited.
TBSI also houses all of our preclinical training in our medical degree. We aim to foster a spirit of interaction and exploration on the frontiers of biomedical research, such that truly ground-breaking discoveries can be made. We have established 3 centres in TBSI - Centre for Cancer Drug Discovery (C2D2), the Centre of Medical Device Technologies (CMDT) and Centre for Translational Medicine. We are also supporting spin out companies such as Trimod Therapeutics, and are working with several pharmaceutical and medical device companies.
The participating Schools are the School of Biochemistry and Immunology, School of Chemistry, School of Medicine, A School of Engineering (Bioengineering), and School of Pharmacy and Pharmaceutical Sciences and they carry out research programmes in a state-of-the-art facility designed to maximise interaction and facilitate co-operation.
We are establishing core technologies of the highest standard, including in NMR and transgenics. TBSI will allow our researchers to continue to perform at the highest level and copper-fasten Trinity's place as a leading international scientific university.
Dr Keith Alden
Operations Manager, TBSI
e: firstname.lastname@example.org@tcd.ie | t: +353 1896 4426
Dr Keith Alden is Operations Manager of the Trinity Biomedical Sciences Institute (TBSI) at Trinity College Dublin. He is a graduate of University College Dublin and holds a PhD in the area of Cell Biology. He trained as a Postdoctoral Fellow in Systems Biology at the Genome Institute in the Agency for Science, Technology and Research in Singapore and spent 5 years working in Asia developing large scale industry/academic collaborations. He returned to Ireland in 2015 and led the industry engagement programme for the Science Foundation Ireland Advanced Materials and Bioengineering Research Centre, AMBER, helping it to be successfully funded for a second 5 year term before joining TBSI. Keith has worked across academia, industry and government agencies to build large interdisciplinary research projects and teams to deliver clear societal and economic outcomes. At TBSI Keith leads an operations team dedicated to providing leading infrastructure and financial management, research support, scientific communication and informed strategy to the Institute and its Researchers